Safety of Oral Vancomycin in Functionally Anephric Patients
Administration of a vancomycin oral solution, 2 g daily for 16 days, to functionally anephric patients without inflammatory bowel disease resulted in assayable but low (≤0.66 μg/ml) serum levels in two of the five volunteers.
Salvato in:
| Pubblicato in: | Antimicrob Agents Chemother |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
1978
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352521/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/718158/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.14.4.634 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|